No abstract available.
C-Reactive Protein* ; Tocolysis*

No abstract available.
C-Reactive Protein*

No abstract available.
C-Reactive Protein* ; Pregnancy*

BACKGROUND: Several immunological abnormalities, such as decreased T-cell interleukin-2 production and abnormal cellular and humoral reactivity to neurons, had been associated with patients who have schizophrenia. Several researches have been conducted to study the correlation of elevated inflammatory markers with the symptomatology of schizophrenia. OBJECTIVES: The aim of this study is to determine the levels of C-reactive protein, which is a general marker for infection and inflammation, in patients with Schizophrenia in acute exacerbation and compare these to the levels of C-reactive protein in patients with Schizophrenia in remission. METHODS: A cross-sectional study was carried out on in-patients at the Veterans Memorial Medical Center Department of Psychiatry. Serum levels of C-reactive protein in adult patients were determined during an acute exacerbation of Schizophrenia. These were compared to Creactive protein levels of patients with Schizophrenia in remission. PASW Statistics 18 (SPSS) was used for data management, tabulation and analysis. RESULTS: Cases of eighty-six (86) patients, seen by the principal investigator during OPD consults were reviewed, 43 of which had Schizophrenia in Acute Exacerbation and also 43 of patients were in Remission. The mean CRP level of patients in acute exacerbation was 7.05 mg/L (SD=0.23), which was higher than the mean CRP level of patients in remission at 5.30 mg/L (SD=0.30). CONCLUSION This study demonstrated that a stronger association exists between an acute exacerbation of Schizophrenia and elevated C-Reactive protein, in the absence of another systemic inflammatory disease when compared to the association between levels of Creactive protein in patients with Schizophrenia, in remission. This finding could pave the way for initiation of studies examining whether adjunct treatment of anti-inflammatory drugs with anti-psychotics will improve disease outcome.
C-Reactive Protein ; Schizophrenia

No abstract available.
Bacterial Infections* ; C-Reactive Protein*

BACKGROUND: For monitoring infection and inflammation episodes, biomarkers of host response, such as C-reactive protein (CRP) and procalcitonin (PCT), are now being recognized as useful tools in the diagnostic process. We aimed at evaluating the analytical performance of the recently developed semi-automated ichroma SMART system (Boditech Med Inc., Korea), which allows measurements of both CRP and PCT. METHODS: We evaluated the analytical performance of the ichroma SMART system and the agreement between its results and the laboratory standards for CRP and PCT measurements. The precision and linearity as well as the method of measurement were compared to the DxC 800 (Beckman Coulter, USA) for CRP and to the VIDAS (bioMerieux SA, France) for PCT, according to corresponding CLSI guidelines. Additionally, we evaluated the carryover rates between specimens. RESULTS: The total precision (% CV) of the ichroma SMART system in measuring low, middle, and high level controls (level 1, 2, 3) was 6.32%, 5.75%, and 3.56% for CRP, and 8.07%, 6.24%, and 6.53% for PCT. In the linearity test, R2 was 0.9997 and 0.9982 for CRP (0.1-336.8 mg/L) and PCT (0.05-60.91 ng/mL), respectively. Good correlation was observed between ichroma SMART and DxC 800 for CRP (r=0.997), and between ichroma SMART and VIDAS for PCT (r=0.992). Carry-over effect was 0.02% for CRP and 0.04% for PCT. CONCLUSIONS: The ichroma SMART system showed an adequate performance and appeared to be a suitable clinical analyzer with a simple operating procedure for the measurement of CRP and PCT.
Biomarkers ; C-Reactive Protein* ; Inflammation

No abstract available.
C-Reactive Protein ; Cardiovascular Diseases

No abstract available.
C-Reactive Protein* ; Neutrophils* ; Ureter*

No abstract available.
C-Reactive Protein* ; Neutrophils* ; Ureter*

Some protein, at acute phase were usually used to diagnose and to monitor the status of inflammation in infection diseases. In healthy person, CRP exists only in the form of patch, but CRP is as an sensitive indicator of a reaction of systemic inflammation, in turn, inflammation had a key role in physiopathology of arteriosclerosis. Person with high content of CRP will have a 4.5 fold risk of heart attack in comparing with healthy one. Moreover it has diverse manifestations in other severe diseases such as blood sugar disorders, dental gingival diseases, smoking, overweight and obese
Inflammation ; C-Reactive Protein ; diagnosis ;